Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

ZeClinics

ZeClinics_logo
21
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Barcelona, Cataluña, Spain

Send a message

  • 23

    employees

Anglais

ZeClinics

Anglais

ZeClinics is a Biotech Contract Research Organization (CRO) and early-phase biopharmaceutical (PHARMA) company using zebrafish for high-throughput safety and efficacy screenings, in pharmaceutical, environmental, chemical, cosmetic or nutritional industries. With clients from 12 different countries worldwide, spanning from biotech up to pharma leaders/large academic centers, and a highly-qualified team, we guarantee a unique "zebrafish experience", as a one-way route of INNOVATION.
The...

See more

ZeClinics is a Biotech Contract Research Organization (CRO) and early-phase biopharmaceutical (PHARMA) company using zebrafish for high-throughput safety and efficacy screenings, in pharmaceutical, environmental, chemical, cosmetic or nutritional industries. With clients from 12 different countries worldwide, spanning from biotech up to pharma leaders/large academic centers, and a highly-qualified team, we guarantee a unique "zebrafish experience", as a one-way route of INNOVATION.
The company is currently preparing a Series A fundraising round to finance ZePharma, the drug discovery branch of ZeClinics. ZePharma has significantly shortened the time took to discover new therapeutic molecules, by utilizing ZeCardio, a zebrafish-based innovative high-throughput screening platform, developed by ZeClinics under the most prestigious grant program from the European Commission, SME Instrument Phase 2. The company is currently developing those molecules in CRISPR-edited pre-clinical models for unmet cardiovascular needs. It is divided into three business units, each with its own research goals, but all commonly started in zebrafish and by applying high throughput screening and “humanized” disease models generated with CRISPR genome editing technology: CardioProtection; Cardiomyopathies; CardioRegeneration; 
The ticket of the investment seeked is of €5.000.000 to cover the upcoming pre-clinical and phase 1 clinical studies, with expected Return of the Investment in 4 years.

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

EUREKA Accelerated
Eureka is the world’s leading network for international R&D collaborations, represented in over 45 countries. It aims to boost the growth of SMEs, large companies, research organisations and universities through funding and supporting international R&D cooperation and providing investment-readiness services Through Eureka’s programmes, organisations can access funding and expert support. The Eureka label is given to companies who have been financed through Eureka programmes.
212 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
1921 Members
Access2EIC – Seal of Excellence
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors. https://access2eic.eu/
2130 Members